Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Gross Profit (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Gross Profit data on record, last reported at $161.2 million in Q4 2025.

  • For Q4 2025, Gross Profit rose 68.63% year-over-year to $161.2 million; the TTM value through Dec 2025 reached $349.6 million, down 4.56%, while the annual FY2025 figure was $349.6 million, 4.56% down from the prior year.
  • Gross Profit reached $161.2 million in Q4 2025 per ORGO's latest filing, up from $97.7 million in the prior quarter.
  • Across five years, Gross Profit topped out at $161.2 million in Q4 2025 and bottomed at $27.8 million in Q2 2025.
  • Average Gross Profit over 5 years is $87.1 million, with a median of $88.4 million recorded in 2022.
  • Peak YoY movement for Gross Profit: surged 90.64% in 2021, then tumbled 72.53% in 2025.
  • A 5-year view of Gross Profit shows it stood at $95.3 million in 2021, then dropped by 7.2% to $88.4 million in 2022, then dropped by 18.69% to $71.9 million in 2023, then soared by 33.0% to $95.6 million in 2024, then skyrocketed by 68.63% to $161.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $161.2 million in Q4 2025, $97.7 million in Q3 2025, and $27.8 million in Q2 2025.